Table 1 The demographic and clinical characteristics of the 488 patients
Characteristics | Frequency (n, %)a |
|---|---|
Sex | |
Male | 274 (56.1) |
Female | 214 (43.9) |
Age (y), mean ± SD | 52.0 ± 15.0 |
18–64 | 371 (76.0) |
≥ 65 | 117 (24.0) |
Diagnosis at admissionb | |
Malignant neoplasms of lip, oral cavity or pharynx (2B60-2B68, 2B6A) | 163 (33.4) |
Diseases or disorders of orofacial complex (DA01, DA04-DA07) | 144 (29.5) |
Benign non-mesenchymal neoplasms (2E90-2E91) | 117 (24.0) |
Benign mesenchymal neoplasms (2E80-2E83) | 35 (7.2) |
In situ neoplasms, except of lymphoid, hematopoietic, central nervous system or related tissues (2E60) | 17 (3.5) |
Others | 12 (2.5) |
Number of patients taking chronic medications | 195 (40.0) |
Number of chronic medication categories | |
1 | 54 (11.1) |
2 | 40 (8.2) |
3 | 33 (6.8) |
4 | 22 (4.5) |
≥ 5 | 46 (9.4) |
Most common chronic medications | |
Nifedipine | 43 (8.8) |
Amlodipine | 35 (7.2) |
Metformin | 34 (7.0) |
Number of patients having comorbidities | 192 (39.3) |
Number of comorbidity categories | |
1 | 84 (17.2) |
2 | 59 (12.1) |
≥3 | 49 (10.0) |
Most common comorbidities | |
Hypertension | 140 (28.7) |
Diabetes | 64 (13.1) |
Dyslipidemia | 47 (9.6) |
Allergies | |
No known drug allergy | 409 (83.8) |
Yes (to one or more medications) | 79 (16.2) |